Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €90.56 EUR
Change Today +0.13 / 0.14%
Volume 0.0
IC7 On Other Exchanges
As of 3:54 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

icu medical inc (IC7) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/22/15 - €90.87
52 Week Low
08/8/14 - €42.13
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ICU MEDICAL INC (IC7)

icu medical inc (IC7) Related Businessweek News

No Related Businessweek News Found

icu medical inc (IC7) Details

ICU Medical, Inc. develops, manufactures, and sells medical devices used in infusion therapy, oncology, and critical care applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient’s vein for use in hospitals and ambulatory clinics. The company’s infusion therapy products include needlefree connector products, such as MicroClave and MicroClave clear, anti-microbial MicroClave, neutrons, NanoClave, and Clave; custom infusion sets; and Tego needlefree hemodialysis connectors. It also provides critical care products used to monitor signs, as well as physiological functions of organ systems. The company’s critical care products comprises hemodynamic monitoring systems, including Transpac disposable pressure transducers, Safeset closed needlefree blood conservation systems, and custom monitoring systems; sensor, pulmonary artery thermodilution, central venous oximetry, and multi-lumen central venous catheters; custom angiography and interventional radiology kits; and Lopez enteral valves. In addition, it offers a line of oncology products that are used to prepare and deliver hazardous medications used in chemotherapy, such as ChemoLock and ChemoClave closed system transfer device and components, and Diana hazardous drug compounding system. The company sells its products to medical product manufacturers, independent distributors, and directly to end users. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.

2,280 Employees
Last Reported Date: 02/20/15
Founded in 1984

icu medical inc (IC7) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $574.2K
Chief Financial Officer, Treasurer and Secret...
Total Annual Compensation: $395.2K
Vice President of Operations
Total Annual Compensation: $390.5K
Vice President and General Manager of Critica...
Total Annual Compensation: $333.6K
Vice President and General Manager of Infusio...
Total Annual Compensation: $315.0K
Compensation as of Fiscal Year 2014.

icu medical inc (IC7) Key Developments

ICU Medical, Inc. - Shareholder/Analyst Call

Annual Meeting of stockholders

ICU Medical, Inc., Annual General Meeting, Jun 15, 2015

ICU Medical, Inc., Annual General Meeting, Jun 15, 2015., at 09:00 Pacific Daylight. Agenda: To elect six directors of the Company to serve for a term of one year or until their successors have been elected and qualified; to ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2015; to hold an advisory vote to approve named executive officer compensation; and to transact such other business as may properly come before the Annual Meeting or any adjournment thereof.

ICU Medical, Inc. Announces Directors Retirement

The Board of Directors of ICU Medical, Inc. adopted a director retirement policy pursuant to which no person may stand for election following his or her 76th birthday and each serving director must resign upon his or her 76th birthday. The policy also requires that as a condition for the nomination of any director who would reach the age of 76 before the end of his or her term, he or she must submit an advance irrevocable resignation that becomes effective on the director's 76th birthday. In accordance with this policy, on April 30, 2015, directors Jack W. Brown and John J. Connors, Esq. delivered letters to the company's Board of Directors tendering their resignations effective as of their respective 76th birthdays, December 13, 2015 and November 21, 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IC7:GR €90.56 EUR +0.13

IC7 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AngioDynamics Inc $15.50 USD +0.29
Cyberonics Inc $61.40 USD -0.46
NxStage Medical Inc $14.28 USD +0.29
Orthofix International NV $33.36 USD -0.10
Wright Medical Group Inc $25.84 USD -0.16
View Industry Companies

Industry Analysis


Industry Average

Valuation IC7 Industry Range
Price/Earnings 54.0x
Price/Sales 5.0x
Price/Book 3.0x
Price/Cash Flow 53.7x
TEV/Sales 3.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ICU MEDICAL INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at